[1]HU XJ,ZHENG WS,ZHU QS,et al.Increase in DNA damage by MYCN knockdown through regulating nucleosome organization and chromatin state in neuroblastoma[J].Front Genet,2019,10:684.
[2]KROESEN M,BLL C,GIELEN PR,et al.Anti-GD2 mAb and Vorinostat synergize in the treatment of neuroblastoma[J].Oncoimmunology,2016,5(6):e1164919.
[3]FAESEN AC,THANASOULA M,MAFFINI S,et al.Basis of catalytic assembly of the mitotic checkpoint complex[J].Nature,2017,542(7642):498-502.
[4]LI HN,ZHENG WH,DU YY,et al.ZW10 interacting kinetochore protein may serve as a prognostic biomarker for human breast cancer:An integrated bioinformatics analysis[J].Oncol Lett,2020,19(3):2163-2174.
[5]YING HN,XU ZY,CHEN MM,et al.Overexpression of Zwint predicts poor prognosis and promotes the proliferation of hepatocellular carcinoma by regulating cell-cycle-related proteins[J].Onco Targets Ther,2018,11:689-702.
[6]AKABANE S,OUE N,SEKINO Y,et al.KIFC1 regulates ZWINT to promote tumor progression and spheroid formation in colorectal cancer[J].Pathol Intl,2021,71(7):441-452.
[7]TANG J,HE D,YANG PR,et al.Genome-wide expression profiling of glioblastoma using a large combined cohort[J].Sci Rep,2018,8(1):15104.
[8]URBANUCCI A,SAHU B,SEPPL J,et al.Overexpression of androgen receptor enhances the binding of the receptor to the chromatin in prostate cancer[J].Oncogene,2012,31(17):2153-2163.
[9]BINENIEK J,CHILDRESS C,SWATSKI MD,et al.COX-2 inhibitors arrest prostate cancer cell cycle progression by down-regulation of kinetochore/centromere proteins[J].Prostate,2014,74(10):999-1011.
[10]YUAN W,XIE SP,WANG M,et al.Bioinformatic analysis of prognostic value of ZW10 interacting protein in lung cancer[J].Onco Targets Ther,2018,11:1683-1695.
[11]YUAN W,XIE SP,LIU P,et al.Digital analysis of immunostaining of ZW10 interacting protein in human lung tissues[J].J Vis Exp,2019,147:10.3791/58551.
[12]ZEID R,LAWLOR MA,POON E,et al.Enhancer invasion shapes MYCN-dependent transcriptional amplification in neuroblastoma[J].Nat Genet,2018,50(4):515-523.
[13]XIANG T,YUAN CH,GUO X,et al.The novel ZEB1-upregulated protein PRTG induced by Helicobacter pylori infection promotes gastric carcinogenesis through the cGMP/PKG signaling pathway[J].Cell Death & Disease,2021,12(2):150.
[14]XU ZZ,ZHOU Y,CAO YX,et al.Identification of candidate biomarkers and analysis of prognostic values in ovarian cancer by integrated bioinformatics analysis[J].Med Oncol,2016,33(11):130.
[15]PENG F,LI Q,NIU SQ,et al.ZWINT is the next potential target for lung cancer therapy[J].J Cancer Res Clin Oncol,2019,145(3):661-673.
[16]JOHNSEN JI,DYBERG C,FRANSSON S,et al.Molecular mechanisms and therapeutic targets in neuroblastoma[J].Pharmacol Res,2018,131:164-176.
[17]BOBOILA S,LOPEZ G,YU J,et al.Transcription factor activating protein 4 is synthetically lethal and a master regulator of MYCN-amplified neuroblastoma[J].Oncogene,2018,37(40):5451-5465.
[18]LIN T,ZHANG YZ,LIN ZM,et al.ZWINT is a promising therapeutic biomarker associated with the immune microenvironment of hepatocellular carcinoma[J].Int J Gen Med,2021,14:7487-7501.
[19]MELAIU O,CHIERICI M,LUCARINI V,et al.Cellular and gene signatures of tumor-infiltrating dendritic cells and natural-killer cells predict prognosis of neuroblastoma[J].Nat Commun,2020,11(1):5992.
[20]徐伟立,时保军,李索林,等.靶向抑制髓系抑制性细胞调控肿瘤微环境对神经母细胞瘤荷瘤小鼠免疫疗效的影响[J].中华小儿外科杂志,2020,41(09):846-854.
XU WL,SHI BJ,LI SL,et al.Regulation of tumor microenvironment by targeted inhibiting of myeloid-derived suppressor cells for influencing immune efficacy of neuroblastoma-bearing mice[J].Chin J Pediatr Surg,2020,41(09):846-854.